Home › Funds › Invenomic Capital Management LP › PATH

Invenomic Capital Management LP position in PATH

UIPATH INC · Technology

Invenomic Capital Management LP reported holding 1,787,590 shares of PATH (UIPATH INC) in its Q2 2026 13F filing — a position valued at US$19.4M, representing 1.16% of its reported portfolio and ranking #31 among its reported holdings. Invenomic Capital Management LP has disclosed PATH holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.79M sh
Reported value held$19.43M
Portfolio Weight1.16%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's PATH position evolved

Invenomic Capital Management LP first disclosed a stake in PATH in Q3 2024 at 355,122 shares (US$4.5M). The position peaked in Q2 2026 at 1,787,590 shares, worth US$19.4M. Across 7 filings, Invenomic Capital Management LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,787,590 shares valued at US$19.4M — an increase of 150,688 shares quarter over quarter.. Notable position changes include a 47% increase in Q1 2025 (shares rose 24% over the following quarter), a 40% trim in Q4 2025 (shares fell 32% over the following quarter), a 147% increase in Q1 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 355.12K $4.55M New
Q4 2024 360.15K $4.58M Add
Q1 2025 528.84K $5.45M Add
Q3 2025 1.10M $14.69M New
Q4 2025 663.43K $10.87M Reduce
Q1 2026 1.64M $18.17M Add
Q2 2026 1.79M $19.43M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PATH and 13F data

PATH (UIPATH INC) is a Technology company. 26 other funds we track also report a position in PATH — the largest reported positions include Tetragon Partners GP Ltd (US$336.4M), Senvest Management, LLC (US$131.4M), Alphabet Inc. (US$76.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PATH

All PATH fund holders →

FAQ

How long has Invenomic Capital Management LP held PATH?

Invenomic Capital Management LP has disclosed PATH holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

What is Invenomic Capital Management LP's current position in PATH?

As of Q2 2026, Invenomic Capital Management LP holds 1.79M shares of PATH (UIPATH INC), valued at $19.43M, representing 1.16% of its reported portfolio and ranking #31.

Has Invenomic Capital Management LP been buying or selling PATH?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in PATH. The position peaked in Q2 2026 at 1.79M shares.

Which other funds hold PATH?

Other major institutional holders of PATH include Tetragon Partners GP Ltd, Senvest Management, LLC, Alphabet Inc., among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.